Stress Disorders, Post-Traumatic
"Stress Disorders, Post-Traumatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
Concept/Terms
Stress Disorders, Post-Traumatic- Stress Disorders, Post-Traumatic
- Post-Traumatic Stress Disorder
- Stress Disorder, Post-Traumatic
- Stress Disorders, Post Traumatic
- PTSD
- Stress Disorder, Post Traumatic
- Neuroses, Posttraumatic
- Posttraumatic Neuroses
- Posttraumatic Stress Disorders
- Posttraumatic Stress Disorder
- Stress Disorder, Posttraumatic
- Stress Disorders, Posttraumatic
- Neuroses, Post-Traumatic
- Neuroses, Post Traumatic
- Post-Traumatic Neuroses
- Post-Traumatic Stress Disorders
- Post Traumatic Stress Disorders
Below are MeSH descriptors whose meaning is more general than "Stress Disorders, Post-Traumatic".
Below are MeSH descriptors whose meaning is more specific than "Stress Disorders, Post-Traumatic".
This graph shows the total number of publications written about "Stress Disorders, Post-Traumatic" by people in Harvard Catalyst Profiles by year, and whether "Stress Disorders, Post-Traumatic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 1 | 9 |
1995 | 10 | 4 | 14 |
1996 | 11 | 2 | 13 |
1997 | 24 | 3 | 27 |
1998 | 20 | 5 | 25 |
1999 | 13 | 3 | 16 |
2000 | 27 | 7 | 34 |
2001 | 26 | 4 | 30 |
2002 | 30 | 3 | 33 |
2003 | 32 | 10 | 42 |
2004 | 36 | 5 | 41 |
2005 | 21 | 11 | 32 |
2006 | 49 | 11 | 60 |
2007 | 44 | 8 | 52 |
2008 | 55 | 5 | 60 |
2009 | 63 | 22 | 85 |
2010 | 56 | 15 | 71 |
2011 | 58 | 14 | 72 |
2012 | 78 | 8 | 86 |
2013 | 96 | 24 | 120 |
2014 | 120 | 16 | 136 |
2015 | 104 | 11 | 115 |
2016 | 117 | 19 | 136 |
2017 | 132 | 16 | 148 |
2018 | 124 | 16 | 140 |
2019 | 124 | 27 | 151 |
2020 | 160 | 12 | 172 |
2021 | 155 | 11 | 166 |
2022 | 161 | 0 | 161 |
2023 | 104 | 1 | 105 |
2024 | 17 | 0 | 17 |
Below are the most recent publications written about "Stress Disorders, Post-Traumatic" by people in Profiles.
-
Post-traumatic stress disorder in a national sample of preadolescent children 9 to 10 years old: Prevalence, correlates, clinical sequelae, and treatment utilization. Transl Psychiatry. 2024 Mar 19; 14(1):152.
-
The impact of PTSD on associations between sex hormones and cardiovascular disease symptoms. Eur J Psychotraumatol. 2024; 15(1):2320993.
-
Co-occurring PTSD in intensive OCD treatment: Impact on treatment trajectory vs. response. J Affect Disord. 2024 May 15; 353:109-116.
-
Enhancing social functioning in older veterans with PTSD: Rationale and design of an intervention and initial RCT. Contemp Clin Trials. 2024 Apr; 139:107485.
-
An EWAS of dementia biomarkers and their associations with age, African ancestry, and PTSD. Clin Epigenetics. 2024 Mar 02; 16(1):38.
-
Pretreatment relationship characteristics predict outcomes from an uncontrolled trial of intensive, multicouple group PTSD treatment. J Fam Psychol. 2024 Apr; 38(3):502-509.
-
Post-traumatic stress disorder as a risk factor for major adverse cardiovascular events: a cohort study of a South African medical insurance scheme. Epidemiol Psychiatr Sci. 2024 Feb 05; 33:e5.
-
Future thinking in PTSD: Preliminary evidence for altered event construction. Psychiatry Res. 2024 Mar; 333:115768.
-
Trauma-related intrusive memories and anterior hippocampus structural covariance: an ecological momentary assessment study in posttraumatic stress disorder. Transl Psychiatry. 2024 Feb 02; 14(1):74.
-
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry Res. 2024 Apr; 334:115764.